Q4 2024 Holdings
Filed 2025-02-14 | 9 holdings | $230.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Beam Therapeutics Inc.(BEAM) | COM | 07373V105 | $112.6M | 4,540,132 | 48.9% |
| Rapport Therapeutics, Inc.(RAPP) | COM | 75383L102 | $66.1M | 3,728,738 | 28.7% |
| Erasca, Inc.(ERAS) | COM | 29479A108 | $27.7M | 11,055,554 | 12.1% |
| Verve Therapeutics, Inc. | COM | 92539P101 | $11.3M | 2,008,809 | 4.9% |
| Gossamer BIO, Inc.(GOSS) | COM | 38341P102 | $7.3M | 8,055,916 | 3.2% |
| Singular Genomics Systems, Inc. | COM NEW | 82933R308 | $2.5M | 126,630 | 1.1% |
| Q32 BIO Inc.(QTTB) | COM | 746964105 | $1.1M | 320,482 | 0.5% |
| Unity Biotechnology, Inc.(UNBX) | COM NEW | 91381U200 | $981.1K | 1,004,817 | 0.4% |
| Cero Therapeutics Holdings, Inc. | CLASS A COM | 71902K105 | $563.6K | 9,393,561 | 0.2% |